Hennion & Walsh Asset Management, Inc. Biogen Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

$2.1 Billion
Q4 2024

A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 2,083 shares of BIIB stock, worth $294,182. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,083

Previous 5,513 62.22%

Holding current value

$294,182

Previous $1.07 Million 70.22%

% of portfolio

0.02%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$146.47 - $191.55 $502,392 - $657,016	-3,430 Reduced 62.22%	2,083 $318,000
Q3 2024 Oct 22, 2024	SELL	$189.07 - $236.8 $241,442 - $302,393	-1,277 Reduced 18.81%	5,513 $1.07 Million
Q2 2024 Jul 19, 2024	SELL	$190.52 - $236.72 $35,055 - $43,556	-184 Reduced 2.64%	6,790 $1.57 Million
Q1 2024 Apr 17, 2024	SELL	$212.02 - $267.71 $19,717 - $24,897	-93 Reduced 1.32%	6,974 $1.5 Million
Q4 2023 Jan 10, 2024	BUY	$222.59 - $267.94 $71,006 - $85,472	319 Added 4.73%	7,067 $1.83 Million
Q3 2023 Oct 27, 2023	BUY	$253.3 - $285.89 $398,440 - $449,704	1,573 Added 30.4%	6,748 $1.73 Million
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $745,652 - $861,624	2,709 Added 109.85%	5,175 $1.47 Million
Q1 2023 Apr 20, 2023	BUY	$256.56 - $292.34 $96,466 - $109,919	376 Added 17.99%	2,466 $686,000
Q4 2022 Jan 12, 2023	BUY	$252.44 - $306.72 $527,599 - $641,044	2,090 New	2,090 $579,000
Q2 2022 Jul 19, 2022	SELL	$187.54 - $223.02 $205,356 - $244,206	-1,095 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$193.77 - $244.14 $109,092 - $137,450	-563 Reduced 33.96%	1,095 $231,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $103,451 - $132,949	-462 Reduced 21.79%	1,658 $398,000
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $29,147 - $38,012	103 Added 5.11%	2,120 $600,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $87,542 - $140,171	-338 Reduced 14.35%	2,017 $698,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $572,147 - $670,303	2,355 New	2,355 $659,000

Others Institutions Holding BIIB

# of Institutions

1,024

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.

Account

Hennion & Walsh Asset Management, Inc. Biogen Inc. Transaction History